Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medication
研究概览
简要总结
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ages 18 and older
- •Idiopathic Parkinson's disease Hoehn and Yahr stage I
- •Fluent in English
- •Appropriate social support if required during an off state.
- •Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
- •Feels comfortable going off PD related medication during in person study visits
- •Lives in the United States
排除标准
- •Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies
- •Any current drug or alcohol abuse.
- •Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
- •Pregnancy, breast-feeding or wanting to become pregnant
- •Physical limitations unrelated to PD that would affect motor ratings
- •Brain surgery
- •Patient is unable to communicate properly with staff (i.e., severe speech problems)
- •Excessive drooling
- •A type of hair style that would impede the use of an EEG cap
- •Sensory abnormalities of the fingertips
- •Nasal dysfunction unrelated to smell loss
结局指标
主要结局
Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medication
时间窗: Baseline, 6 months, 12 months, 18 months, 24 months
This scale measures motor ability within Parkinson's patients. For part 3, the scales minimum values is 0 and max value is 132. Higher scores indicate more impaired motor ability, while lower scores indicate less impaired motor ability. A score of 0 indicates no motor impairment. Assessment will be performed while participants are off PD medication.
次要结局
- Parkinsons disease quality of life questionnaire-39 (PDQ-39)(Baseline, 6 months, 12 months, 18 months, 24 months)
- Freezing of gait questionnaire (FOG)(Baseline, 6 months, 12 months, 18 months, 24 months)
- Smell threshold(Baseline, 6 months, 12 months, 18 months, 24 months)
- Visual acuity(Baseline, 6 months, 12 months, 18 months, 24 months)
- Movement disorders unified Parkinson's rating scale (MDS-UPDRS) part 1(Baseline, 6 months, 12 months, 18 months, 24 months)
- Movement disorders unified Parkinson's rating scale (MDS-UPDRS) part 2(Baseline, 6 months, 12 months, 18 months, 24 months)
- Visual contrast sensitivity(Baseline, 6 months, 12 months, 18 months, 24 months)
- Movement disorders unified Parkinson's rating scale (MDS-UPDRS) part 4(Baseline, 6 months, 12 months, 18 months, 24 months)
- Smell Identification(Baseline, 6 months, 12 months, 18 months, 24 months)
- Smell discrimination(Baseline, 6 months, 12 months, 18 months, 24 months)
- Spontaneous EEG beta band power(Baseline, 6 months, 12 months, 18 months, 24 months)
研究者
Vivek P. Buch
Protocol Director
Stanford University